University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven

OPTIMAL DOSE OF TOCILIZUMAB FOR THE TREATMENT OF GIANT CELL ARTERITIS: EFFICACY, SAFETY, AND EXPOSURE-EFFICACY ANALYSIS FROM GIACTA (2017) Stone JH, Tuckwell K, Dimonaco S, Klearman M, Mallalieu NL, Aringer M, Blockmans D, et al. Conference contribution Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study (2017) Feagan BG, Sandborn WJ, D'Haens G, Panes J, Kaser A, Ferrante M, Louis E, et al. Journal article Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (2017) Pavel ME, Singh S, Strosberg JR, Bubuteishvili-Pacaud L, Degtyarev E, Neary MP, Carnaghi C, et al. Journal article The frequency and influence of dementia risk factors in prodromal Alzheimer's disease (2017) Bos I, Vos SJ, Froelich L, Kornhuber J, Wiltfang J, Maier W, Peters O, et al. Journal article The epidemic of methylisothiazolinone: a European prospective study (2017) Schwensen JF, Uter W, Bruze M, Svedman C, Goossens A, Wilkinson M, Gimenez Arnau A, et al. Journal article Guidelines for the presentation of contact allergy case reports (2017) Uter W, Goossens A, Goncalo M, Johansen JD Journal article Mapping and predicting mortality from systemic sclerosis (2017) Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, et al. Journal article STAG1 mutations cause a novel cohesinopathy characterised by unspecific syndromic intellectual disability (2017) Lehalle D, Mosca-Boidron AL, Begtrup A, Boute-Benejean O, Charles P, Cho MT, Clarkson A, et al. Journal article Trial of Tocilizumab in Giant-Cell Arteritis (2017) Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al. Journal article Six Versus Twelve Months Clopidogrel Therapy after Drug-Eluting Stenting in Patients with Acute Coronary Syndrome: An ISAR-SAFE Study Subgroup Analysis (2016) Lohaus R, Michel J, Mayer K, Lahmann AL, Byrne RA, Wolk A, Ten Berg JM, et al. Journal article